Latest AWMSG advice
- 23/02/2022
- inclisiran (Leqvio®)
-
-
-
AWMSG advice: Recommended with restrictions
- 23/02/2022
- clostridium botulinum type A toxin-haemagglutinin complex (Dysport®)
-
-
-
AWMSG advice: Recommended
- 23/02/2022
- buprenorphine (Sixmo®)
-
-
-
AWMSG advice: Not recommended
- 23/02/2022
- ravulizumab (Ultomiris®)
-
-
-
AWMSG advice: Recommended
- 10/12/2021
- cannabidiol (Epidyolex®)
-
-
-
AWMSG advice: Recommended
- 10/12/2021
- clostridium botulinum neurotoxin type A (Xeomin®)
-
-
-
AWMSG advice: Recommended
- 10/12/2021
- dabigatran etexilate (Pradaxa®)
-
-
-
AWMSG advice: Recommended
- 10/12/2021
- rivaroxaban (Xarelto®)
-
-
-
AWMSG advice: Recommended
- 25/11/2021
- glecaprevir / pibrentasvir (Maviret®)
-
-
-
AWMSG advice: Recommended
- 24/09/2021
- amikacin liposomal (Arikayce®)
-
-
-
AWMSG advice: Recommended
- 24/09/2021
- etravirine (Intelence®)
-
-
-
AWMSG advice: Recommended
- 30/09/2021
- dolutegravir (Tivicay®)
-
-
-
AWMSG advice: Recommended
- 30/09/2021
- amikacin liposomal (Arikayce®)
-
-
-
AWMSG advice: Recommended
- 30/09/2021
- everolimus (Votubia®)
-
-
-
AWMSG advice: Recommended
- 30/09/2021
- nitisinone (Orfadin®)
-
-
-
AWMSG advice: Recommended